Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Indivior Share News (INDV)
INDV Share
Price
INDV Share
News
INDV Share
Chat
INDV Share
Trades2,517
INDV
Live RNS
INDV Share
Charts
INDV Broker
Ratings
INDV Directors
Deals
INDV Financial
Diary
INDV
Fundamentals
INDV Short
Positions1
INDV
Media
INDV Company
Research
INDV Company
Timeline1
- There is currently no data for INDV
Indivior News
Indivior publishes new research on opioid use disorder
(Sharecast News) - Indivior has published two pieces of clinical research supporting its treatments for opioid use disorder.
Indivior publishes new research on opioid use disorder
(Sharecast News) - Indivior has published two pieces of clinical research supporting its treatments for opioid use disorder.
Indivior's Sublocade May Work Better At Higher Dose For Some Patients
LONDON (Alliance News) - Indivior PLC on Monday said analysis of its Sublocade slow-release injectable found the drug could be more effective as an ad...
LONDON MARKET PRE-OPEN: Sports Direct Offers To Rescue Debenhams
LONDON (Alliance News) - Stock prices in London are seen opening in the red on Monday tracking Asian equity markets lower despite better-than-expected...
Indivior Study Proves Long-Term Efficiency Of Sublocade Injections
LONDON (Alliance News) - Indivior PLC on Friday said that its RECOVER study found that 75% of patients with opioid addiction were abstinent from illic...
FTSE 250 movers: Charter Court and Onesavings buoyant on merger news
(Sharecast News) - London's FTSE 250 was up 0.06% at 19,058.77 in afternoon trade on Monday, as merger news fuelled the index's rise.
Indivior Non-Executive Director Yvonne Greenstreet To Retire
LONDON (Alliance News) - Indivior PLC on Friday said Non-Executive Director Yvonne Greenstreet has confirmed that she will retire at the end of March,...
Indivior Publishes Encouraging Results From Sublocade Addiction Trial
LONDON (Alliance News) - Indivior PLC on Thursday said the patient-centred outcome endpoints from its phase three trial of Sublocade in opioid use dis...
Follow the stocks
